Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $14.5M | $13.8M | $1.6M | $7.9M | $1.8M | $404.0K | $6.9M | $8.0M |
| Cost of revenue | $6.3M | $6.5M | $1.4M | $20.2M | $11.2M | $28.2M | $14.0M | $0 |
| Gross profit | $8.2M | $7.3M | $186.0K | −$12.3M | −$9.4M | −$27.8M | −$7.1M | $8.0M |
| Gross margin | 56.7% | 53.1% | 11.5% | -155.3% | -515.6% | -6887.9% | -102.3% | 100.0% |
| R&D | $10.4M | $14.4M | $12.3M | $20.2M | $11.2M | $28.2M | $14.0M | $3.2M |
| Operating income | −$9.2M | −$13.4M | −$19.6M | −$24.5M | −$21.0M | −$40.2M | −$21.5M | −$6.4M |
| EBITDA | −$8.1M | −$12.6M | −$19.5M | −$21.8M | −$20.9M | −$39.4M | −$21.1M | −$5.6M |
| Net income | −$9.0M | −$13.0M | −$16.3M | −$25.9M | −$20.9M | −$39.5M | −$20.7M | −$5.7M |
| Net margin | -61.8% | -93.8% | -1002.1% | -327.7% | -1147.3% | -9782.4% | -297.6% | -71.1% |
| EPS (diluted) | -282.12 | -316.76 | -234.41 | -386.21 | -38.37 | -22.14 | -7.36 | -0.96 |
Annual figures · source: Financial Modeling Prep
No one on the platform currently holds FRTX.
No tracked institution reports a position in FRTX as of their last filing.
| Execution date | Ratio |
|---|---|
| 2022-07-05 | 1-for-45reverse |
| 2016-05-27 | 1-for-10reverse |
No one on the platform has traded FRTX yet.
| $323 |
| — |
| NEUPNeuphoria Therapeutics Inc. | $4.40 | -3.72% | $24M | — |
| TCDATricida, Inc. | $0.11 | +0.00% | $6M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
$FRTX Biotech's tough road. FRTX dissolving after strategic review. No merger partners found. Cutting losses, returning cash to shareholders. Promising pipeline couldn't overcome market challenges. Watching closely for potential IP value. a closer look at current performance: https://beyondspx.com/article/fresh-tracks-therapeutics-frtx-a-biotech-in-dissolution-navigating-an-uncertain-path
View on StockTwits ↗$FRTX Fresh Tracks Therapeutics, Inc. (NASDAQ:FRTX): Navigating the Dissolution and Maximizing Shareholder Value https://beyondspx.com/article/fresh-tracks-therapeutics-inc-frtx-navigating-a-challenging-path-ahead
View on StockTwits ↗$FRTX Fresh Tracks Therapeutics, Inc. (FRTX): Navigating a Challenging Path Ahead https://beyondspx.com/article/fresh-tracks-therapeutics-inc-frtx-navigating-a-challenging-path-ahead
View on StockTwits ↗@geegor @Chickyboy @HoeBiden420 if you look at the company's language and compare it over time you will probably come to a similar conclusion as me, people just don't read anymore and I've traded these situations before like $SIOX $FRTX and find that people don't understand the dynamics unless the company spells it out super clearly like $SIOX (and companies generally don't understand these situations) like $FRTX and $GHSI hence the revisions
View on StockTwits ↗@Chickyboy @HoeBiden420 in the state of Delaware there is a contingency reserve requirement for dissolution which the company has indicated it will holdback throughout the liquidation process. See $GHSI filings, or the $SIOX liquidation recently or $FRTX which is in process still because it didn't get a shareholder vote, etc.
View on StockTwits ↗$FRTX Fresh Tracks Therapeutics, Inc. (NASDAQ:FRTX): Navigating the Dissolution and Maximizing Shareholder Value http://beyondspx.com/2024/08/03/fresh-tracks-therapeutics-inc-nasdaqfrtx-navigating-the-dissolution-and-maximizing-shareholder-value/
View on StockTwits ↗$FRTX new insider buying: 21528 shares. http://insiderbuyingselling.com/?t=FRTX
View on StockTwits ↗$FRTX new insider buying: 17378 shares. http://insiderbuyingselling.com/?t=FRTX
View on StockTwits ↗$FRTX new insider buying: 297 shares. http://insiderbuyingselling.com/?t=FRTX
View on StockTwits ↗$OPK $IMUX $FRTX https://wallstreetwaves.com/immunic-and-2-other-stocks-under-2-insiders-are-buying/
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.